No. |
Variant name |
Chromosome position |
Chromatin state |
Related regulatory elements |
Target genes |
Extended variants |
Associated traits |
1 |
rs28387074 |
chr2:127412013-127412014 |
Weak transcription Enhancers
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
2 |
rs540275384 |
chr2:127412048-127412049 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
3 |
rs559925026 |
chr2:127412080-127412081 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
4 |
rs532142029 |
chr2:127412098-127412099 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
5 |
rs193245631 |
chr2:127412099-127412100 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
6 |
rs568842054 |
chr2:127412115-127412116 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
7 |
rs531620273 |
chr2:127412124-127412125 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
8 |
rs550740667 |
chr2:127412153-127412154 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
9 |
rs78672084 |
chr2:127412168-127412169 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
10 |
rs536353401 |
chr2:127412175-127412176 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
11 |
rs553465327 |
chr2:127412206-127412207 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
12 |
rs539618601 |
chr2:127412266-127412267 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
13 |
rs113931201 |
chr2:127412308-127412309 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
14 |
rs28387075 |
chr2:127412320-127412321 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
15 |
rs528375191 |
chr2:127412324-127412325 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
16 |
rs188479231 |
chr2:127412325-127412326 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
17 |
rs192947176 |
chr2:127412332-127412333 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
18 |
rs372962915 |
chr2:127412336-127412337 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
19 |
rs551709719 |
chr2:127412357-127412358 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
20 |
rs138177042 |
chr2:127412404-127412405 |
Enhancers Flanking Active TSS Weak transcription
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
21 |
rs28387076 |
chr2:127412405-127412406 |
Enhancers Flanking Active TSS Weak transcription
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
22 |
rs28387077 |
chr2:127412407-127412408 |
Enhancers Flanking Active TSS Weak transcription
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
23 |
rs554269543 |
chr2:127412478-127412479 |
Enhancers Flanking Active TSS Weak transcription
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
24 |
rs28387078 |
chr2:127412495-127412496 |
Enhancers Flanking Active TSS Weak transcription
|
TF binding region
|
1 gene(s)
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
25 |
rs539967833 |
chr2:127412517-127412518 |
Enhancers Flanking Active TSS Weak transcription
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
26 |
rs559788773 |
chr2:127412539-127412540 |
Enhancers Flanking Active TSS Weak transcription
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
27 |
rs530603100 |
chr2:127412547-127412548 |
Enhancers Flanking Active TSS Weak transcription
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
28 |
rs908640 |
chr2:127412558-127412559 |
Enhancers Flanking Active TSS Weak transcription
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
29 |
rs184031556 |
chr2:127412624-127412625 |
Enhancers Bivalent Enhancer Flanking Active TSS Weak transcription
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
30 |
rs188613491 |
chr2:127412628-127412629 |
Enhancers Bivalent Enhancer Flanking Active TSS Weak transcription
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
31 |
rs28387079 |
chr2:127412633-127412634 |
Enhancers Bivalent Enhancer Flanking Active TSS Weak transcription
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
32 |
rs531555645 |
chr2:127412690-127412691 |
Enhancers Bivalent Enhancer Flanking Active TSS Weak transcription
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
33 |
rs142602138 |
chr2:127412696-127412697 |
Enhancers Bivalent Enhancer Flanking Active TSS Weak transcription
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
34 |
rs561138631 |
chr2:127412702-127412703 |
Enhancers Bivalent Enhancer Flanking Active TSS Weak transcription
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
35 |
rs115171907 |
chr2:127412715-127412716 |
Enhancers Bivalent Enhancer Flanking Active TSS Weak transcription
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
36 |
rs79957745 |
chr2:127412716-127412717 |
Enhancers Bivalent Enhancer Flanking Active TSS Weak transcription
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
37 |
rs191869720 |
chr2:127412721-127412722 |
Enhancers Bivalent Enhancer Flanking Active TSS Weak transcription
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
38 |
rs539123360 |
chr2:127412728-127412729 |
Enhancers Bivalent Enhancer Flanking Active TSS Weak transcription
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
39 |
rs552850220 |
chr2:127412793-127412794 |
Enhancers Bivalent Enhancer Flanking Active TSS Weak transcription
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
40 |
rs569385208 |
chr2:127412794-127412795 |
Enhancers Bivalent Enhancer Flanking Active TSS Weak transcription
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
41 |
rs536413467 |
chr2:127412847-127412848 |
Enhancers Bivalent Enhancer Flanking Active TSS Weak transcription
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
42 |
rs538164782 |
chr2:127412920-127412921 |
Enhancers Bivalent Enhancer Flanking Active TSS Weak transcription
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
43 |
rs146909678 |
chr2:127413028-127413029 |
Flanking Active TSS Bivalent Enhancer Enhancers Flanking Bivalent TSS/Enh Active TSS Weak transcription
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
44 |
rs28387080 |
chr2:127413056-127413057 |
Flanking Active TSS Bivalent Enhancer Enhancers Flanking Bivalent TSS/Enh Active TSS Weak transcription
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
45 |
rs28387081 |
chr2:127413101-127413102 |
Flanking Active TSS Bivalent Enhancer Enhancers Flanking Bivalent TSS/Enh Active TSS Weak transcription
|
TF binding region
|
1 gene(s)
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
46 |
rs553337779 |
chr2:127413114-127413115 |
Flanking Active TSS Bivalent Enhancer Enhancers Flanking Bivalent TSS/Enh Active TSS Weak transcription
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
47 |
rs3811541 |
chr2:127413135-127413136 |
Flanking Active TSS Bivalent Enhancer Enhancers Flanking Bivalent TSS/Enh Active TSS Weak transcription
|
TF binding region
|
1 gene(s)
|
LD-proxies of rSNPOverlapped rCNV
|
mRNA abundance
|
48 |
rs141438116 |
chr2:127413145-127413146 |
Flanking Active TSS Bivalent Enhancer Enhancers Flanking Bivalent TSS/Enh Active TSS Weak transcription
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
49 |
rs183765634 |
chr2:127413147-127413148 |
Flanking Active TSS Bivalent Enhancer Enhancers Flanking Bivalent TSS/Enh Active TSS Weak transcription
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
50 |
rs189328377 |
chr2:127413168-127413169 |
Flanking Active TSS Bivalent Enhancer Enhancers Flanking Bivalent TSS/Enh Active TSS Weak transcription
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|